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through three determinants of b
iour: opportunity (eg, access), ca
ity (eg, knowledge) and moti
(eg, trust).19
Little is known about how an
GPs do use AR in CVD risk a7) · 7 October 2013Objectives:  To identify factors that influence the extent to which general 
practitioners use absolute risk (AR) assessment in cardiovascular disease (CVD) 
risk assessment.
Design, setting and participants:  Semi-structured interviews with 25 currently 
practising GPs from eight Divisions of General Practice in New South Wales, 
Australia, between October 2011 and May 2012. Data were analysed using 
framework analysis.
Results:  The study identified five strategies that GPs use with patients in 
different situations, defined in terms of the extent to which AR was used and the 
reasons given for this: the AR-focused strategy, used when AR assessment was 
considered useful for the patient; the AR-adjusted strategy, used to account for 
additional risk factors such as family history; the clinical judgement strategy, 
used when GPs considered that their judgement took multiple risk factors into 
account as effectively as AR; the passive disregard strategy, used when GPs 
lacked sufficient time, access or experience to use AR; and the active disregard 
strategy, used when AR was considered to be inappropriate for the patient. The 
strategies were linked with different opportunity, capability and motivation 
barriers to the use of AR.
Conclusions:  This study provides an in-depth insight into the factors that 
influence GPs’ use of AR in CVD risk assessment. The results suggest that GPs 
use a range of strategies in different situations, so different approaches may be 
required to improve the use of AR guidelines in practice.
Abstractur
va
ve
absolute 
C rent guidelines for cardio-scular disease (CVD) pre-ntion advocate the use of
risk (AR) assessment to
guide the use of preventive medica-
tion, rather than treating blood pres-
sure and cholesterol separately.1
Numerous AR models have been
developed, including the Framingham
risk equation on which the Australian
guidelines are based.2-5 Age, sex,
smoking, diabetes, systolic blood
pressure and cholesterol ratio are
used to estimate the risk of a cardio-
vascular event in the next 5 years.
Preventive medication is recom-
mended if AR is higher than 15%, or
10%–15% with other risk factors.2,3
Reviews suggest that the AR
approach may improve the clinical
management of CVD without harm to
patients.6,7 Basing treatment decisions
on high AR rather than high individ-
ual risk factors may prevent overtreat-
ment of patients with isolated risk
factors but low to moderate overall
risk, and undertreatment of patients
with high overall risk.8,9
However, international10-13 and
Australian14-18 research suggests that
CVD risk management is not consist-
ently based on AR. Possible barriers to
general practitioners using AR assess-
ment include lack of time, accessibil-
ity, knowledge and trust; conflicting
guidelines; difficulty understanding
and explaining AR; and focusing on
individual risk factors that may not be
included in AR models.10-18 According
to the “behaviour change wheel”
framework, these factors may act as
barriers to the use of AR assessment
ehav-
pabil-
vation
d why
ssess-
ment, and the alternative strategies
employed when AR is not the focus of
assessment. We aimed to investigate
GPs’ views and experiences of CVD
risk assessment to identify factors that
influence the extent to which Austral-
ian AR assessment guidelines are used.
Methods
We used purposive sampling to
recruit participants, aiming for maxi-
mum variation among a set of charac-
teristics known to influence CVD risk
management (Box 1).20-22 Invitation
letters were posted to all 3743 mem-
bers of eight Divisions of General
Practice in metropolitan New South
Wales. Of 55 GPs who returned
expression of interest forms, we allo-
cated 25 to this study. GPs signed a
consent form before participating in
person (two participants) or via tele-
phone (23 participants). They received
$100 for their time. Preliminary analy-
sis suggested saturation of key themes
related to the range of CVD risk
assessment strategies described by
GPs, so no further recruitment was
conducted.23 Ethics approval was
obtained through the Sydney Local
Health District Human Research Eth-
ics Committee.
A semi-structured interview sched-
ule covering CVD risk assessment and
management was developed (Appen-
dix 1; online at mja.com.au), piloted
with two GPs, and clarified. Inter-
views lasted between 22 and 55 min-
utes,  and de-identified audio-
recordings were transcribed verbatim.
Between October 2011 and May 2012,
interviews were conducted by two of
us (C B, S M) who have qualifications
in public health.
We used a framework analysis
method24 and summarised data
within a matrix, with participants as
rows and themes as columns. This
allowed synthesised data to be exam-
ined within and across themes and
participants to identify consistent pat-
terns and relationships within the
data. Three of us (C B, S M, J J) devel-
oped the coding framework (matrix)
by independently identifying themes
within a subset of data using both
deductive (researcher-driven) and
inductive (response-based) methods.
Themes were discussed to develop a
preliminary coding scheme, which
was discussed and reviewed with K M
(experienced qualitative researcher) to
achieve the final coding scheme. Rig-
our was addressed by: an iterative
Researchprocess of constant comparison to
code and analyse the data; double
coding; discussing emerging themes
(C B, S M, J J, K M); documenting the
analysis process; and discussing the
analysis with all authors, including
two academic GPs (J D, P G).25 The
study used a phenomenological
methodology to understand GPs’
experiences and perspectives on clini-
cal practice, and the analysis repre-
sents the perspective of psychosocial
health researchers, epidemiologists
and academic GPs working in public
health.24
Results
GPs’ use of AR assessment varied
widely, from closely following the
guidelines to rejecting these in favour
of other priorities for patient care. GPs
often described a general preference
regarding their use of AR tools (charts
and calculators) in CVD risk assess-
ment, but patient factors also influ-
enced the use of AR. Five different
assessment strategies were identified
(see Box 2; and Appendix 2, online at
mja.com.au).  While some GPs
appeared to have a general preference
for using or not using AR, all GPs
described using a range of strategies.
Box 3 provides examples of how indi-
vidual GPs with a general preference
used different strategies in different
situations.
Strategy 1 — AR focused: The AR-
focused strategy involved using AR
tools to assess risk, because it was
seen as a more objective method than
relying on clinical judgement. GPs
described using this strategy because
they viewed guidelines as important,
trusted the AR model, and described
AR tools as convenient, easy to use,
objective, scientific, evidence-based
and helpful regarding treatment deci-
sions. AR tools based on different
risk-prediction models were some-
times used if they were seen to be
more comprehensive than the Fram-
ingham model.
I’m comfortable to be guided by
the experts rather than try and
invent too much on what might
be dodgy assumptions on my
part. (ID31, male, 30 years’ expe-
rience)
The AR-focused strategy was con-
sidered most helpful for particular
patient situations: to justify the deci-
sion to treat or not treat the patient
with medication, especially “border-
line” patients with some risk factors
but not enough to make them obvi-
ously at high risk; to motivate or
“scare” resistant patients who are at
moderate or high risk, particularly
smokers and males; and to reassure
concerned patients who are at low
risk.
When it’s a grey kind of area it
helps give me an idea whether I
should be using drug therapy.
(ID37, female, 26 years’ experi-
ence)
AR assessment was considered
more helpful for patients without
additional risk factors like family his-
tory and obesity, as these factors are
not included in AR tools but GPs
considered them to have a strong
influence on risk. It was also used
more often when patients specifically
requested a general health check, and
for patients who wanted more evi-
dence for the recommended manage-
ment approach.
Strategy 2 — AR adjusted: This strat-
egy was based on the perception that
considering more risk factors would
result in a more accurate risk assess-
ment. GPs using AR tools would
sometimes adjust the risk upwards if
additional risk factors were present,
particularly family history and being
overweight, or adjust the risk down-
wards if the patient had a particularly
healthy lifestyle. This adjustment was
usually done subjectively, but some
GPs described a quantitative adjust-
ment to the AR percentage or risk
level (eg, moderate to high).
The calculator of course doesn’t
include certain factors . . . if
someone does do a lot of exer-
cise I would . . . think their risk
is probably lower. (ID16, male, 9
years’ experience)
I can’t say it’s 8% on the risk
calculator so therefore it’s going
to be 10%, I can’t do that. But I
will say it’s greater than that.
(ID11, female, 27 years’ experi-
ence)
Strategy 3 — clinical judgement: The
clinical judgement strategy was used
when GPs considered that their clini-
cal judgement took multiple risk fac-
tors into account as effectively as AR.
This involved making a subjective
assessment of the patient’s overall risk
based on a wide range of risk factors,
including lifestyle.
We actually know the patient
quite well and their background
and their habits now so it’s eas-
ier for us to make an overall
assessment. (ID6, female, 19
years’ experience)
GPs used this strategy when they
felt that AR tools would not take all
the relevant risk factors into account.
Some GPs attributed their ability to
use clinical judgement to having more
experience in practice.
[AR assessment] doesn’t take
into account your family his-
tory, your weight, if you’re
active or not . . . when you’ve
been in this game for as many
years as I have you like to get a
big picture. (ID22, male, 22
years’ experience)
The clinical judgement strategy was
used more for patients with risk fac-
tors that were not explicitly included
in Australian AR tools, such as family
history of CVD or obesity. It was also
used when the patient was considered
to be obviously at low risk (no risk
1 General practitioner characteristics 
(n = 25)
Characteristic Number
Sex
Female 15
Age, years
< 40 6
40–49 8
50–59 7
60+ 4
Years of practice
< 10 5
10–19 6
20–29 9
30+ 5
GP role in practice
Registrar/in training 1
Contractor/sessional/ 
retainer/salaried
14
Partner/principal 10
Medical record system
Electronic only 23
Electronic and paper 1
Paper only 1
Number of GPs in practice
1–5 10
6–10 13
11–15 22MJA 199 (7) · 7 October 2013
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2  General practition
Strategy Descripti
AR focused AR used 
considere
appropria
AR 
adjusted
AR adjus
down to a
additiona
Clinical 
judgement
Clinical ju
considere
better tha
Passive 
disregard
AR not us
lack of tim
experienc
Active 
disregard
AR reject
considere
or inappr
patient
AR = absolute risk. CVD =
opportunity, capability afactors) or obviously at high risk (mul-
tiple or strong risk factors).
Strategy 4 — passive disregard: The
passive disregard strategy was used
when there was insufficient time or
access, or the GP had insufficient
experience to use AR tools. This gen-
erally resulted in a focus on individual
risk factors rather than overall CVD
risk. GPs who described this strategy
often acknowledged that they should
be using AR more often.
I could just never find them [AR
charts] when I needed them so
. . . it’s being able to put your
finger on it when you need it
and if it was available. I don’t
even know if it’s available on
our computer program. (ID1,
female, 16 years’ experience)
The passive disregard strategy was
also used if the patient expected
assessment based on individual risk
factors, or their management had
always been focused on one isolated
risk factor. There was a perception
that the AR concept was too complex
or too confusing for some patients.
A lot of patients don’t have that
idea of overall risk . . . they are
very much blood pressure,
cholesterol, they don’t have the
c oncept of putt ing i t  a ll
together. (ID45, male, 10 years’
experience)
Strategy 5 — active disregard: The
active disregard strategy involved
deciding not to assess AR when it was
seen as limited, irrelevant or inappro-
priate for individual patients. GPs
described using this strategy for a
range of reasons: viewing guidelines
as flexible or irrelevant to the individ-
ual patient, concern about overservic-
ing asymptomatic patients with
unnecessary and costly assessments,
and being more focused on other pri-
orities, such as lifestyle risk factors.
I’ve not used the cardiovascular
risk assessment terribly much
lately because we find that
really at the end of the day the
whole thing is just weight
reduction. (ID36, male, 25 years’
experience)
Discussing AR was seen as unhelp-
ful for particular types of patients: less
literate patients who may not under-
stand it; patients at low risk who were
highly anxious and may perceive even
a low percentage risk as worrying; and
patients at low risk who had lifestyle
risk factors and may be less motivated
to change if shown they had a low AR.
Often people come out with a
really low risk and then they
think they [can] continue with
. . . their obesity and high blood
pressure. (ID29, female, 25 years’
experience)
This strategy was also used by GPs
if the patient was seen to be uninter-
ested in CVD risk, particularly if they
had set another agenda for the con-
sultation or were very resistant to dis-
cussing lifestyle. CVD risk was not
generally discussed if the GP felt the
patient had more important health
problems.
Discussion
Our findings suggest that GPs use a
range of strategies to assess overall
CVD risk. While some GPs appeared
to have a general preference for using
or not using AR, all GPs described
using different strategies in different
situations.
The main facilitators for using AR
assessment were trusting AR tools
over clinical judgement, uncertainty
about treating patients who were bor-
derline high risk, and opportunities to
motivate patients at high risk or reas-
sure patients at low risk. GPs’ descrip-
tions o f  a lte rnative  st rategies
demonstrated a range of barriers to
the use of AR assessment, based on
the behaviour change wheel frame-
work.19 Opportunity barriers included
limited consultation time, lack of
accessible AR tools and patient resist-
ance. The first two  of these were
often described by GPs using a pas-
sive-disregard assessment strategy,
while patient resistance was a reason
for using an active-disregard strategy.
Capability barriers included uncer-
tainty about additional factors not
included in the AR model, and poor
er and patient factors related to the use of absolute cardiovascular risk assessment
Reasons for using strategy
on GP factors Patient factors Targets to improve GP use of AR*
when 
d useful and 
te for patient
Follow guidelines in general; familiar with AR 
model and tools; trust AR as more objective
Borderline for medical treatment; no additional 
risk factors; request general health check; 
interested in evidence; high risk and need 
motivation; low risk and need reassurance
Capability: guidance on the use of 
Framingham versus alternative AR 
models
ted up or 
ccount for 
l risk factors
Follow guidelines in general; familiar with AR 
model and tools; trust AR as more objective
Additional risk factors not specified in AR tools 
(adjust upwards); very healthy lifestyle (adjust 
downwards)
Capability: uncertainty about how 
to account for risk factors perceived 
to be outside of the AR model
dgement 
d as good or 
n AR
Clinical judgement considered to take more 
risk factors into account; more experienced, so 
think they can use clinical judgement to assess 
risk
Obviously low risk; obviously high risk; 
additional risk factors not specified in AR tools
Motivation: perception that clinical 
judgement is as good or better than 
AR
ed due to 
e, access or 
e
Not familiar with guidelines or AR tools; view 
time and access as barriers, and may 
acknowledge they should use AR more
Used to individual risk factor assessment; 
previous consultations focused on monitoring 
one isolated risk factor
Opportunity: external barriers to AR 
assessment. Capability: poor 
knowledge of AR model and tools. 
Motivation: focus on individual risk 
factors out of habit or routine
ed when 
d unhelpful 
opriate for 
See guidelines as flexible or limited; concerned 
about cost or overservicing; population-based 
approach not seen as relevant to individual 
patients; focused on patient’s agenda; focused 
on lifestyle risk factors
Not interested in CVD risk; more important 
health problems than CVD risk; low risk but 
could improve lifestyle; low risk but highly 
anxious; unlikely to understand AR percentage
Opportunity: patient barriers to AR 
assessment. Motivation: belief that 
AR is not helpful for individual 
patients
cardiovascular disease. * Categories based on Michie et al’s “behaviour change wheel” framework, which outlines three determinants of behaviour: 
nd motivation (including both automatic and conscious processes, eg habits and goals).19 ◆7) · 7 October 2013
Researchknowledge of available guidelines
and tools. Uncertainty about addi-
tional risk factors led GPs to use an
AR-adjusted or clinical-judgement
strategy. Poor knowledge of AR tools
was related to using a passive-disre-
gard strategy. Motivation barriers
included a preference for clinical
judgement of overall risk, routine
use of individual risk factor assess-
ment, and competing priorities (eg,
other health issues, patient prefer-
ences), which were associated with
clinical-judgement, passive-disre-
gard and active-disregard strategies,
respectively.
The opportunity and capability bar-
riers described above are in line with
previous research on the barriers to
AR assessment, but they have not
previously been linked to alternative
assessment strategies used in clinical
practice.10,12,18 Motivational barriers
have not been a major focus in previ-
ous research on ways to improve the
use of AR guidelines in practice.
However, our findings suggest that
motivation helps explain the incon-
sistent use of AR guidelines by GPs.
Researchers have previously sug-
gested improving the consultation
process and developing more accessi-
ble AR tools, which would remove
some opportunity and capability bar-
riers.10,16 The assessment strategies
that we have identified suggest that
an educational approach is also
needed to remove capability and
motivational barriers. Even when
assessment was based on the recom-
mended Framingham risk model, GPs
appeared to need clarification on the
role of additional risk factors, particu-
larly family history and weight. These
risk factors are included in Australian
guidelines, but not as part of the AR
assessment. By subjectively adjusting
AR scores for these factors, GPs were
reducing the predictive value of the
assessment,  and were treating
untested risk factors (family history)
in the same way as tested but non-
significant predictors (body mass
index) in the Framingham model.4
This is consistent with previous
research on the use of clinical decision
rules in practice.26 The inclusion of
different risk factors in alternative AR
models may reinforce this approach,
even though they predict different
outcomes and are not interchange-
able.1,5 The belief that including more
risk factors results in a better AR
assessment was common among par-
ticipants in our study, leading some to
use clinical judgement rather than AR
tools. However, they found it difficult
to describe how they integrated mul-
tiple risk factors, and previous
research has shown that clinical
judgement of overall CVD risk is inac-
curate.15 This is an important issue
because inaccurate risk assessment
has consequences for both overtreat-
ment and undertreatment.8,9
The range of assessment strategies
described by our data could inform
future research on improving the use
of AR guidelines in primary care, and
could be used to address motivational
barriers to the use of AR guidelines.
However, a focus on increasing AR
assessment overall may not reflect the
complexities of primary care — GPs
may have good reasons for not fol-
lowing guidelines, including patient
preferences.27,28 GPs’ concerns about
competing priorities warrant further
investigation into how guidelines can
reconcile a patient-centred approach
with prevention targets.
The strengths of our study include a
heterogeneous sample, rigorous ana-
lysis process, and involvement of GPs
throughout the research process. The
main limitations are that the partici-
pants may have been more or less
supportive of using AR assessment
than GPs in the wider community,
and that self-report may differ from
actual practice.
This study provides an in-depth
insight into the factors that influence
GPs’ use of AR in the assessment of
CVD risk. GPs described using a
range of strategies in different situa-
tions. These were linked to opportu-
nity, capabil ity and motivation
barriers to the use of AR assessment,
w h i ch  may  re q u i r e  d i f f e re n t
approaches to improve the use of AR
guidelines in practice.
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